Skip to main content

Dr Ajai Garg, the head of Digital Group at Anand and Anand, talks about ways to curb the menace of DeepFake on The Newshour Agenda on TimesNow. Mincing no words to stress on the responsibility of intermediaries to check the fake contents being hosted on their platforms. Dr Garg says it is time to remove the veneer of Safe Harbour.

In response to queries from Executive Editor Madhavdas Gopalakrishnan, Dr Garg cites the Anil Kapoor Deepfake matter where Team Anand and Anand engendered a John Doe order to bring the internet platforms to do their bit to check the menace of deepfakes violating the personality rights of the actor.

Catch the episode here: https://www.youtube.com/watch?v=KfmztRjonjI  where Dr Garg shares the platform with actor Manvi Taneja, Author Sanjay Jha and Abhijit Iyer Mitra, Senior Fellow IPCS as they discuss the who and how of a solution to Deepfakes.

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 07, 2026

Pharmaceutical innovation and access to medicines are closely connected aspects of public health. While patent protection can encourage investment in research

Can Public Health Override a Pharmaceutical Patent? The BPaL Patent Dispute in India
News & Updates, Thought Leadership
•
Nov 04, 2026

Imagine discovering an Instagram account using your company’s name, a website offering products under a deceptively similar identity, or an AI-generated

Can AI Steal Your Brand Identity? Trademark Squatting and AI Misuse in India
News & Updates, Thought Leadership
•
Nov 02, 2026

First published by AsiaIP. Author: Lakshmidevi Somanath Copyright law has traditionally addressed the asymmetry between the costs of creating a work and

What is Copyright Worth When Machines Do the Creating? Lessons from Streaming and Gaming
News & Updates, Thought Leadership
•
Oct 31, 2026

A startup has developed a new technology, filed a patent application and begun building its product. The filing is an important milestone. But what happens

Your Startup Has Filed a Patent. Now What? The Commercial Value of IP